Dare Bioscience
women health is our sole focus women health an efficient investment thesis approximately of research is invested in female specific conditions beyond oncology women health conditions outside of oncology comprise less than of the current pipeline we believe investment in women health will be efficient and disproportionately women health products make up of total blockbuster products while contributing to of total blockbuster sales women control of purchasing decisions a | Dare Bioscience
Company
Deck date
February 2023
Slide
4 of 54
Similar slides by Dare Bioscience
Investor Presentation
October 2022
Related slides by other companies
Investor Presentation
April 2023
Fixed Income
May 2023
Fixed Income
June 2007
Results
November 2024
Other recent decks by Dare Bioscience
Results
November 2023
Investor Presentation
August 2023
Investor Presentation
July 2023
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies